Are you Dr. Willman?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 24 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
2325 Camino de Salud NE
UNM Cancer Research Treatment Center
Albuquerque, NM 87131Phone+1 505-272-5622- Is this information wrong?
Summary
- Dr. Cheryl Willman, MD is a board certified pathologist in Albuquerque, New Mexico. She is currently licensed to practice medicine in New Mexico. She is affiliated with University of New Mexico Hospitals and is a Professor at University of New Mexico School of Medicine.
Education & Training
- University of New Mexico School of MedicineResidency, Pathology-Anatomic and Clinical, 1981 - 1984
- Mayo Clinic College of Medicine and Science (Rochester)Residency, Pathology-Anatomic and Clinical, 1981 - 1981
- Mayo Clinic College of MedicineClass of 1981
Certifications & Licensure
- NM State Medical License 1985 - 2025
- American Board of Pathology Anatomic Pathology
Clinical Trials
- S0301 Cyclosporine, Daunorubicin, and Cytarabine in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia Start of enrollment: 2004 Jul 01
- S0535, Gemtuzumab and Combination Chemotherapy in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia Start of enrollment: 2007 Nov 15
- S9031-S9126-S9333-S9500-A, Studying Bone Marrow and Blood Samples From Patients With Acute Myeloid Leukemia Start of enrollment: 2008 Nov 01
- Join now to see all
Publications & Presentations
PubMed
- Examining the impact of age on the prognostic value of ELN-2017 and ELN-2022 acute myeloid leukemia risk stratifications: a report from the SWOG Cancer Research Network.Christina M Termini, Anna Moseley, Megan Othus, Frederick R Appelbaum, Thomas R Chauncey, Harry P Erba, Min Fang, Stanley C Lee, Jasmine Naru, Era L Pogosova-Agadjanya...> ;Haematologica. 2023 Nov 1
- 1 citationsPriorities to Promote Participant Engagement in the Participant Engagement and Cancer Genome Sequencing (PE-CGS) Network.Anne Lr Schuster, Norah L Crossnohere, Melinda Bachini, Cindy K Blair, John D Carpten, Elizabeth B Claus, Graham A Colditz, Li Ding, Bettina F Drake, Ryan C Fields, Ka...> ;Cancer Epidemiology, Biomarkers & Prevention. 2023 Apr 3
- Verification of prognostic expression biomarkers is improved by examining enriched leukemic blasts rather than mononuclear cells from acute myeloid leukemia patients.Era L Pogosova-Agadjanyan, Xing Hua, Megan Othus, Frederick R Appelbaum, Thomas R Chauncey, Harry P Erba, Matthew P Fitzgibbon, Isaac C Jenkins, Min Fang, Stanley C Le...> ;Biomarker Research. 2023 Mar 16
- Join now to see all
Press Mentions
- FDA’s Fashoyin-Aje: Draft Guidance on Accelerated Approval Urges Reliance on Randomized Controlled TrialsMarch 31st, 2023
- Eclipse and Mayo Clinic Create Nucleus RadioPharma to Better Serve Cancer PatientsOctober 12th, 2022
- $100 Million Gift from Fred C. And Katherine B. Andersen Foundation to Expand Mayo Clinic’s Proton Beam Therapy Services in MinnesotaOctober 10th, 2022
- Join now to see all
Hospital Affiliations
- University of New Mexico HospitalsAlbuquerque, New Mexico